Adaptimmune Therapeutics plc
ADAP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$71 | -$114 | -$165 | -$158 |
| Dep. & Amort. | $11 | $9 | $6 | $7 |
| Deferred Tax | $0 | $0 | $0 | $6 |
| Stock-Based Comp. | $12 | $12 | $18 | $21 |
| Change in WC | -$37 | -$25 | -$2 | $135 |
| Other Non-Cash | $11 | -$24 | $1 | $7 |
| Operating Cash Flow | -$73 | -$141 | -$142 | $11 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$5 | -$30 | -$9 |
| Net Acquisitions | $0 | $45 | $78 | $0 |
| Inv. Purchases | -$100 | -$76 | -$48 | -$140 |
| Inv. Sales/Matur. | $44 | $211 | $167 | $224 |
| Other Inv. Act. | $0 | $1 | -$78 | -$0 |
| Investing Cash Flow | -$59 | $177 | $89 | $76 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $50 | $0 | $0 | $0 |
| Stock Issued | $29 | $1 | $13 | $3 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1 |
| Financing Cash Flow | $79 | $1 | $13 | $3 |
| Forex Effect | -$0 | $1 | -$2 | $0 |
| Net Chg. in Cash | -$54 | $37 | -$42 | $90 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $147 | $110 | $152 | $61 |
| End Cash | $93 | $147 | $110 | $152 |
| Free Cash Flow | -$76 | -$146 | -$172 | $2 |